Recruiting Heart Attack Studies in Fountain Valley
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA)....
About Heart Attack Clinical Trials in Fountain Valley
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Fountain Valley, CALIFORNIA. These studies are seeking a combined 2,211 participants. Research is being sponsored by Pfizer, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Fountain Valley — FAQ
Are there heart attack clinical trials in Fountain Valley?
Yes, there are 2 heart attack clinical trials currently recruiting in Fountain Valley, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fountain Valley?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.
Are clinical trials in Fountain Valley free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov